The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant buzz within the UK , prompting a notable shift in hormone trends. Obtaining these compounds remains a complex landscape, with National Health Service approval currently limited and specialist practices offering prescriptions at a premium . Concerns